Pfizer has submitted clinical data to Health Canada regarding an oral medication it is hoping can be used to treat mild to moderate cases of COVID-19 in adults.
Its antiviral pill is called PAXLOVID, and is intended to be given to adults aged 18 and over who have a confirmed case of COVID-19 and are at an increased risk of developing severe illness.that the pill is designed to block the activity of an enzyme in SARS-CoV-2 that is essential for the virus to replicate itself, and also help to slow the breakdown of the pill’s ingredients in order to help combat the virus for longer.
Both Merck and Pfizer have agreed to allow other countries to manufacture their antiviral medications, although Pfizer’s has yet to be approved anywhere.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Union recommends Cargill’s new offer at Alberta meat-packing plant hit with large COVID-19 outbreakIf workers accept the deal, it would avert a strike or a lockout that could begin as early as Monday
Read more »
Are the immune system's own antibodies responsible for long COVID?Are the immune system's own antibodies responsible for long COVID? — via healthing_ca
Read more »
Union recommends Cargill’s new offer at Alberta meat-packing plant hit with large COVID-19 outbreakIf workers accept the deal, it would avert a strike or a lockout that could begin as early as Monday
Read more »